The use and cost of HIV service provision in England in 1996

PharmacoEconomics

Volumn 14, Issue 6, 1998, Pages 639-652

  Beck, Eduard J ^a   Tolley, Keith ^b   Power, Amanda ^a   Mandalia, Sundhiya ^a   Rutter, Philippa ^a   Izumi, Junichi ^a   Beecham, Jeni ^c   Gray, Alistair ^d   Barlow, David ^e   Easterbrook, Philippa ^f   Fisher, Martin ^g   Innes, John ^h   Kinghorn, George ⁱ   Mandel, Bibhat ^j   Pozniak, Anton ^k   Tang, Allan ^l   Tomlinson, David ^m   Williams, Ian ⁿ  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF KENT   (United Kingdom)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^g ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^h BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

ⁱ ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^j NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^k KING S COLLEGE HOSPITAL   (United Kingdom)

^l ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^m ST MARY S HOSPITAL   (United Kingdom)

ⁿ MIDDLESEX HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; COMBINATION CHEMOTHERAPY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; UNITED KINGDOM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMBULATORY CARE FACILITIES; ENGLAND; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HIV INFECTIONS; HUMANS; MALE; PATIENT ADMISSION; PROSPECTIVE STUDIES;

EID: 0032425554     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199814060-00005     Document Type: Article

References (48)

1. Beck EJ, Kennelly J, McKevitt C, et al. Changing use of hospital services and costs at a London AIDS referral centre 1983-1989. AIDS 1994; 8: 367-77
2. Beck EJ, Whitaker L, Kennelly J, et al. Changing presentation and survival, service utilization and costs for AIDS patients: insights from a London referral centre. AIDS 1994; 8: 379-84
3. Rees M, Roberts B, Brindle S. AIDS/HIV: the cost of the service in Riverside D.H.A. London: AIDS Costing Project. Department of Health, 1988
4. Rees M. The cost of AIDS/HIV in the Oxfordshire Health District. London: AIDS Costing Project, Department of Health, 1989
5. Rees M. The cost of AIDS/HIV in the Brighton District. London: AIDS Costing Project, Department of Health, 1989
6. Johnson AM, Adler MW, Crown JM. The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus cost of care and prevention in an inner London district. BMJ 1986; 293: 489-92
7. Johnson AM, Shergold C. Hawkins A, et al. Patterns of hospital care for patients with HIV infection and AIDS. J Epidemiol Community Health 1993; 47: 232-7
8. Kennelly JM, Tolley KH, Ghani ACH, et al. Hospital costs of treating haemophilic patients infected with HIV. AIDS 1995; 9: 787-93
9. Morton A, McCallum A, Parkin D, et al. The cost of caring for patients with HIV infection and AIDS. Newcastle upon Tyne: Department of Epidemiology and Public Health, University of Newcastle upon Tyne, 1994
10. Nageswaran A, Kingdom G, Shen R, et al. Hospital service utilization by HIV/AIDS patients and their management cost in a Provincial Genitourinary Medicine Department, Int J STD AIDS 1995; 6: 336-44
11. Tolley K, Gyldmark M. Towards a standardized framework for costing HIV and AIDS treatment and care in Europe. In: Fitzsimons D, Hardy V, Tolley K, editors. The economic and social impact of AIDS in Europe. London: Cassell, 1995: 25-39
12. Curtis H. Funding implications of combination therapies J HIV Comb Ther 1997; 2: 27-8
13. Beck EJ, Glandt M. The National Prospective Monitoring System on the Use, Cost and Outcome of HIV Service Provision in English Hospitals: feasibility report to the NPMS working party 1994. London: Academic Department of Public Health, St. Mary's Hospital Medical School, 1994
14. Beck EJ. National Prospective Monitoring System on the Use, Cost and Outcome of HIV Service Provision in English Hospitals: summary review and business plan 1997-2001. London: Coordinating and Analytic Centre, Department of Epidemiology & Public Health. Imperial College School of Medicine at St. Mary's, 1997
15. Bennett C. Health care and risk in the new NHS: issues around commissioning services. In: Coles E, Smith D, Tombs S, et al., editors. Risk management and society. Kluwer Academic Publishers. In press
16. Forte P. Bowen T. HIV/AIDS care and treatment costs: forward planning. A report commissioned by The AIDS Awareness Trust. London: AIDS Awareness Trust, 1996
17. Department of Health. £23 Million boost for next year's HIV/AIDS treatment budget [press release]. London: Department of Health, 1997 Oct 27
18. SAS/STAT User's Guide. Version 6. 4th ed. Cary (NC): SAS Institute Inc. 1990
19. Centres for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41 (RR-17): 1-19
20. Public Health Laboratory Service (PHLS) AIDS Centre. AIDS surveillance and HIV death clinical report form, London: PHLS Communicable Disease Surveillance Centre, 1493
21. Beck EJ. The National Prospective Monitoring System on the Use, Cost and Outcome of HIV Service Provision in English Hospitals: outcomes 1994-1996. An Extra-Ordinary NPMS Steering Group Meeting, Imperial College School of Medicine at St. Mary's; 1997 Jan 30; London
22. Kinghorn G. The National Prospective Monitoring System on the Use. Cost and Outcome of HIV Service Provision in English Hospitals. NPMS Steering Group Meeting, Imperial College School of Medicine at St. Mary's; 1997 Sep 22; London
23. National Health Service (NHS) Executive. Hospital and community health services revenue (pay and prices) inflation index. Leeds: NHS Executive Finance and Performance Department A. 1997
24. Petrou S, Dooley M, Whitaker L, et al. Community services for people with HIV infection in London: a prospective study of cost and utilization patterns. Health Trends 1995; 27: 62-8
25. Beck EJ, Tolley K, Financing HIV services in England: estimated impact of the cost of anti-retroviral therapy. Im J STD AIDS 1998; 9: 512-7
26. HIV and STD Division, Communicable Disease Surveillance Centre. AIDS/HIV quarterly surveillance tables: UK data to the end December 1997. Colindale: Public Health Laboratory Service AIDS Centre, 1998
27. Beck EJ, Flori YA, Geoffard PY, et al. Uptake of combination anti-retroviral therapy during 1996 and 1997: an Anglo-French comparison [abstract 42289]. 12th World AIDS Conference: 1998 Jun 28-Jul 3: Geneva
28. Finkler SA. The distinction betwreen cost and charges. Ann Intern Med 1982; 96: 102-9
29. Beck EJ, Mandalia S, Griffith R, et al. The Hospital and Community Services Study of Families with HIV Infection: initial analyses of hospital service provision and costs for HIV-infected children St. Mary's Hospital, 1986-1994. London: Department of Epidemiology and Public Health, Imperial College School of Medicine at St. Mary's, 1997
30. Beck EJ, Kupek EJ, Petrou S, et al. Survival and the use and costs of hospital services for London AIDS patients treated with AZT. Int J STD AIDS 1996; 7: 507-12
31. Hammer SM. Advances in antiretroviral therapy and viral load monitoring. AIDS 1996; 10 Suppl. 3: S1-11
32. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV infected adults with CD4 cell counts between 200 and 500 per cubic millimeter. N Engl J Med 1996; 335: 1081-90
33. Saravolatz LD, Winslow DI, Collins G, et al. Zidovudine alone or in combination with didanosine or zalcitabine in HIV infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. N Engl J Med 1996; 335: 1099-106
34. Delta Coordinating Committee. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996; 348: 283-91
35. Williams IG. Use of prolease inhibitors. J HIV Comb Ther Ther 1996; 1:4-7
36. Perelson AS, Essunger P, Cao Y-z, et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 1997; 387: 188-91
37. Brown R, Simpson KN, Nabulsi A. Cost and consequences of adding ritonavir to current antiretroviral therapy for advanced HIV patients in the United Kingdom and in the USA [abstract WeB 3126]. XI International Conference on AIDS: 1996 Jul 7-12: Vancouver
38. Simpson K, Revicki D, Nabulsi A, et al. Adding ritonavir to current antiretroviral therapy tor advanced HIV patients in the US: comparison of costs of care predicted by modelling and actual costs from trial setting [abstract ThB 4112]. XI International Conference on AIDS: 1996 Jul 7-12: Vancouver
39. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. JAMA 1997; 277: 1962-9
40. Minimum standard of care (for adults with HIV). London: Treatment Action Taskforce, 1996
41. Gazzard B, Moyle GJ, Weber J, et al. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997; 349: 1086-92
42. Gazzard B, Moyle GJ, British HIV Association Guidelines Writing Committee. 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1998; 352: 314-6
43. Direction des Hospitaux, Mission SIDA. DM12: an information system built around the patient. Paris. INSERM-SC4, Ministere de la Sante et de l'action Humanitaire. 1993
44. Pozniak A. Surrogacy in HIV-1 clinical trials. Lancet 1998; 351: 536-7
45. Lange JM. Current problems and the future of antiretroviral drug trails. Science 1997; 276: 548-50
46. Beck EJ, Kupek EJ, Wadsworlh J, et al. The use and cost of hospital services by patients with different AIDS defining conditions treated at a national London AIDS referral centre. J Public Health Med 1996; 18: 457-64
47. Dijkgraaf MGW, Luijhen AHP, Jager JC, et al. Inpatient care for symptomatic HIV-infected persons: a longitudinal study of hospitalizations, inpatient drug use and related costs. AIDS Care 1995; 7: 321-36
48. Postma MJ, Tolley K, Leidl RM, et al. Hospital care for persons with AIDS in the European Union: assessment of current and future impact controlled for severity-stages. Health Policy 1997; 41: 157-76